News

Oct 02 2019

RANK Software Closes a $1.85M Financing Round Led by GreenSky Capital

Toronto, ON – October 2, 2019 GreenSky Capital Inc. is pleased to announce that its affiliated venture fund, the GreenSky Accelerator Fund III, has led a $1.85 million equity investment round in RANK Software. The financing included participation from the GreenSky Accelerator Fund III, members of the affiliated angel group, the GreenSky President’s Club, MaRS […]

Sep 30 2019

LabsCubed Closes Financing Co-led by GreenSky Accelerator Fund and MaRS Investment Accelerator Fund.

Toronto, ON – September 30, 2019 GreenSky Capital Inc. is pleased to announce that its affiliated venture fund, the GreenSky Accelerator Fund III, and MaRS Investment Accelerator Fund (IAF), have co-led a funding round in LabsCubed, an innovative Waterloo company focused on industrial automation. Additional funding was provided by angel investors, including members of Golden […]

Aug 20 2019

Akira Health Acquired by Telus

Toronto – August 20, 2019 FOR IMMEDIATE RELEASE On July 31, 2019, Telus Health acquired Akira Health (“Akira”), a portfolio company of the GreenSky Accelerator Fund I, for undisclosed terms.  The GreenSky Accelerator Fund I had invested in Akira in 2017. Akira’s virtual care platform was built with a vision to bring world-class, affordable healthcare […]

Jul 03 2019

Wave Financial Acquired by H&R Block

Toronto – July 3, 2019 FOR IMMEDIATE RELEASE On July 1, 2019, H&R Block acquired Wave Financial, Inc. (“Wave”) for C$536M.  Wave had been a client of GreenSky Capital in its previous incarnation as a broker/dealer.  At that time, GreenSky advised Wave on  its first two rounds of investment – the first through members of […]

Jun 04 2019

Weever closes $1M equity round co-led by GreenSky and MaRS IAF

Toronto, ON – June 4, 2019 GreenSky Capital Inc. is pleased to announce that its affiliated venture fund, the GreenSky Accelerator Fund III, and MaRS Investment Accelerator Fund (IAF) have co-led a $1 million equity investment round in Weever Apps. GreenSky Capital, through its affiliated venture funds, the GreenSky Accelerator Fund I and the GreenSky […]

Apr 08 2019

Cyclica: the subject of a recent Financial Post Article

Toronto, ON – April 8, 2019 A recent Financial Post article prominently showcased two Canadian companies – Cyclica and Deep Genomics – who are at the forefront of applying Artificial Intelligence in the field of drug discovery and innovation. The Financial Post Article, which appeared in the National Post on April 3, 2019, notes that […]

Apr 05 2019

Pyrowave: the subject of a recent CBC Report

Toronto, ON – April 4, 2019 A recent CBC report showcased Pyrowave as one of three companies in Canada aiming to address the problem of how to efficiently recycle styrofoam. As the CBC report noted, 80 percent of styrofoam waste in Canada and 94 per cent in the United States is not currently being recycled. […]

Jan 29 2019

AI-powered Insurtech ProNavigator Closes 2 Million Equity Financing

Kitchener-Waterloo, ON – January 28, 2018 ProNavigator, a technology platform company using artificial intelligence (AI) to reinvent the customer experience and drive growth in the insurance industry, has closed its latest seed round of equity financing, bringing its total funding to over $2 million. The round was co-led by GreenSky the Capital MaRS Investment Accelerator […]

Dec 21 2018

Cyclica drives new research capabilities for Merck KGaA, Darmstadt, Germany, through its AI Augmented Screening Platform

TORONTO — December 20, 2018 Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that it has entered into a licensing agreement with Cyclica Inc. for the use of Ligand Express®, a cloud-based in silico proteome screening platform. Ligand Express® is a structure-based and artificial intelligence (AI) augmented proteome screening platform that is […]

Nov 27 2018

Cyclica Drives Drug Discovery Through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer

TORONTO — November 26, 2018 Cyclica (www.cyclicarx.com), a Bayer G4A company is pleased to announce a collaboration with Bayer to advance drug discovery programs by gaining insights into the polypharmacological profiles of small molecules, while further evolving Cyclica’s integrated network of enabling technologies. Through a multi-phase collaboration, Cyclica will provide its cloud-based proteome screening Ligand […]